Fmoc-4-(neopentyloxysulfonyl)-Abu-OH
目录号 : GA21482Orthogonally protected derivative of homocysteic acid. As a Glu substitute, or for introducing a highly acidic moiety, it can be incorporated into various peptide effectors, such as receptor ligands and enzyme inhibitors. The neopentyl sulfonate can be cleaved with HF/m-cresol or by slow hydrolysis in 0.1% TFA in water/acetonitrile. This cysteic acid homolog occurs in nature; homocysteic acid, generated from plasma homocysteine, can damage endothelial tissue.
Cas No.:220951-81-5
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Orthogonally protected derivative of homocysteic acid. As a Glu substitute, or for introducing a highly acidic moiety, it can be incorporated into various peptide effectors, such as receptor ligands and enzyme inhibitors. The neopentyl sulfonate can be
Cas No. | 220951-81-5 | SDF | |
分子式 | C24H29NO7S | 分子量 | 475.56 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.1028 mL | 10.5139 mL | 21.0278 mL |
5 mM | 0.4206 mL | 2.1028 mL | 4.2056 mL |
10 mM | 0.2103 mL | 1.0514 mL | 2.1028 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。